Deutsche Bank analyst George Hill lowered the firm’s price target on GoodRx (GDRX) to $6 from $8 and keeps a Hold rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GDRX:
- GoodRx Holdings: Strategic Growth and Revised Projections Support Buy Rating Despite Short-term Adjustments
- GoodRx downgraded to Outperform from Strong Buy at Raymond James
- Positive Outlook for GoodRx Holdings Amid Strategic Initiatives and Market Expansion Opportunities
- GoodRx Reports Steady Q2 2025 Financial Results
- Closing Bell Movers: DoorDash jumps 8%, Airbnb slips 6% on earnings